Education
About Us
Working with TipRanks
Follow Us
MICHAEL D DALE Insider Profile
18 Followers
MICHAEL D DALE, SVP at Abbott Laboratories, holds 63.54K shares in AxoGen (Ticker: AXGN), holds 45.13K shares in Abbott Laboratories (Ticker: ABT). Most recently, MICHAEL D DALE Sold ― shares of AxoGen on Dec 12, 2025 for an estimated value of $750.00K.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+12.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 10, 2022 - Mar 10, 2023
Return:+15.60%
The most profitable trade made by MICHAEL D DALE
MICHAEL D DALE's Trading History
Abbott Laboratories
Mar 02, 2023
SVP
Uninformative Sell
614.81K
$5.66M
AxoGen
Dec 12, 2025
CEO
Informative Sell
750.00K
$1.93M
List of latest transactions for each holding click on a transaction to see MICHAEL D DALE's performance on stock
You May Also Like
MICHAEL D DALE insider profile FAQ
What is the percentage of profitable transactions made by MICHAEL D DALE?
The percentage of profitable transactions made by MICHAEL D DALE is 100%.
What is the average return per transaction made by MICHAEL D DALE?
The average return per transaction made by MICHAEL D DALE is 12.10%.
What stocks does MICHAEL D DALE hold?
MICHAEL D DALE holds: ABT, AXGN stocks.
What was MICHAEL D DALE’s latest transaction?
MICHAEL D DALE latest transaction was an Informative Sell of $750.00K.
What was MICHAEL D DALE's most profitable transaction?
MICHAEL D DALE’s most profitable transaction was an Informative Sell of ABT stock on March 10, 2022. The return on the trade was 15.60%.
What is MICHAEL D DALE's role in Abbott Laboratories?
MICHAEL D DALE's role in Abbott Laboratories is SVP.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.